DE3614278A1 - Pharmazeutische praeparate mit gefaessschuetzender wirkung - Google Patents

Pharmazeutische praeparate mit gefaessschuetzender wirkung

Info

Publication number
DE3614278A1
DE3614278A1 DE19863614278 DE3614278A DE3614278A1 DE 3614278 A1 DE3614278 A1 DE 3614278A1 DE 19863614278 DE19863614278 DE 19863614278 DE 3614278 A DE3614278 A DE 3614278A DE 3614278 A1 DE3614278 A1 DE 3614278A1
Authority
DE
Germany
Prior art keywords
coenzyme
preparations according
vascular protective
effect
aescin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
DE19863614278
Other languages
German (de)
English (en)
Inventor
Pierre-Noel Genf/Genève Brasey
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sigma Tau Industrie Farmaceutiche Riunite SpA
Original Assignee
Seuref AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Seuref AG filed Critical Seuref AG
Publication of DE3614278A1 publication Critical patent/DE3614278A1/de
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/15—Suppositories

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Molecular Biology (AREA)
  • Cardiology (AREA)
  • Dermatology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
DE19863614278 1985-04-30 1986-04-26 Pharmazeutische praeparate mit gefaessschuetzender wirkung Granted DE3614278A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH1826/85A CH662505A5 (it) 1985-04-30 1985-04-30 Composizioni farmaceutiche ad azione protettiva vascolare.

Publications (1)

Publication Number Publication Date
DE3614278A1 true DE3614278A1 (de) 1986-10-30

Family

ID=4219499

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19863614278 Granted DE3614278A1 (de) 1985-04-30 1986-04-26 Pharmazeutische praeparate mit gefaessschuetzender wirkung

Country Status (10)

Country Link
US (1) US4707360A (https=)
JP (1) JPS61280424A (https=)
KR (1) KR860007927A (https=)
AT (1) AT393793B (https=)
BE (1) BE904696A (https=)
CH (1) CH662505A5 (https=)
DE (1) DE3614278A1 (https=)
FR (1) FR2587212B1 (https=)
GB (2) GB8610147D0 (https=)
NL (1) NL8601105A (https=)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996018403A1 (en) * 1994-12-16 1996-06-20 Ks Biomedix Ltd. Combined use of diclofenac and tribenoside to treat osteoarthritis

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0383171A3 (en) * 1989-02-11 1991-07-24 Hoechst Aktiengesellschaft 2,3,23-trihydroxy-urs-12-ene derivatives for treating cognitive disorders
FR2645442A1 (fr) * 1989-04-07 1990-10-12 Gueyne Jean Produit therapeutique a base de compose organique du silicium et de polyamine polycarboxylee, particulierement utile pour le traitement de l'atherome
GB8926715D0 (en) * 1989-11-28 1990-01-17 Haessle Ab Improvements relating to the administration of pharmaceutical agents
IE911403A1 (en) * 1990-04-26 1991-11-06 Cytrx Corp Compositions and method for topical treatment of damaged or¹diseased tissue
FR2661830B1 (fr) * 1990-05-11 1992-09-04 Corbiere Jerome Nouvelle compositions pharmaceutiques a base de flavonoside.
US5234914A (en) * 1991-06-11 1993-08-10 Patent Biopharmaceutics, Inc. Methods of treating hemorrhoids and anorecial disease
US5399584A (en) * 1992-05-05 1995-03-21 The Procter & Gamble Company Use of flavone derivatives for gastroprotection
FR2692145B1 (fr) * 1992-06-10 1995-05-05 Bellon Labor Sa Roger Nouvelle composition à usage topique contenant de la diosmine.
IT1265312B1 (it) * 1993-12-21 1996-10-31 Indena Spa Formulazioni contenenti carotenoidi e procarotenoidi associati a polifenoli nella prevenzione dei danni da abnorme produzione di
US5683678A (en) * 1995-03-09 1997-11-04 The Procter & Gamble Company Oral compositions
JP2001504514A (ja) * 1996-11-27 2001-04-03 ドング クック ファーマシューティカル シーオー．，エルティーディー． アシアト酸誘導体を有効成分とする痴呆及び認識障害治療剤
KR100530278B1 (ko) 1997-02-28 2006-04-06 동국제약 주식회사 아시아트산 유도체를 유효성분으로 하는 간 보호 및치료제
US6077534A (en) * 1997-09-02 2000-06-20 Klinge Pharma Gmbh Production of pharmaceutical formulations for treatment of edema and venous disorders
US6159494A (en) * 1997-12-03 2000-12-12 Widgerow; Alan D Treatment of post operative scars with a tape containing a gel from Bulbine frutescens
US6423742B1 (en) 1999-09-02 2002-07-23 Drake Larson Compositions for reducing vascular plaque formation and methods of using same
US6562864B1 (en) 1999-09-02 2003-05-13 Drake Larson Catechin multimers as therapeutic drug delivery agents
ATE287723T1 (de) * 1999-09-10 2005-02-15 Ceteris Holding B V Amsterdam Ein antioxydierungsmittel auf basis von pflanzenextrakten zur behandlung von kreislaufs- und chronischen degenerativen problemen und von bluthochdruck
DE60019314T2 (de) * 1999-09-10 2006-04-27 Ceteris Holding B.V.-Amsterdam (Olanda) - Succursale Di Lugano Ein antioxyrierungsmittel auf basis von pflanzenextrakten zur behandlung von kreislaufs- und fettsuchtproblemen
WO2002069992A1 (en) * 2001-03-02 2002-09-12 Biopharmacopae Design International Inc. Plant extracts and compositions comprising extracellular protease inhibitors
JP2002293736A (ja) * 2001-03-30 2002-10-09 Sunstar Inc メーラード反応阻害剤およびそれを含有する組成物
DE20109044U1 (de) * 2001-05-30 2001-08-09 Weber & Weber GmbH & Co. KG, 82266 Inning Pharmazeutische Zubereitung
US6981883B2 (en) * 2001-11-14 2006-01-03 Fci Americas Technology, Inc. Impedance control in electrical connectors
WO2004064543A1 (ja) * 2003-01-17 2004-08-05 Taiyo Kagaku Co., Ltd. コエンザイムq10含有組成物
US20070122492A1 (en) * 2004-11-18 2007-05-31 Stephen Behr Plant extracts and dermatological uses thereof
US20070010459A1 (en) * 2005-01-14 2007-01-11 Ying Liu Application of asiatic acid and its derivatives to treat pulmonary fibrosis
US8071139B2 (en) * 2008-09-04 2011-12-06 Alan David Widgerow Treatment of damaged skin
US8591961B2 (en) 2008-09-04 2013-11-26 Allergan, Inc. Aesthetic treatment of scars and aging skin
EP2353596A1 (en) * 2010-02-02 2011-08-10 SIGMA-TAU Industrie Farmaceutiche Riunite S.p.A. Combination composition, comprising as active ingredients L-carnitine or propionyl L-carnitine, for the prevention or treatment of chronic venous insufficiency

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1157269B (it) * 1982-03-19 1987-02-11 Seuref Ag Nuove formulazioni farmaceutiche contenenti il coenzima q10 adatte per la somministrazione topica
CH655005A5 (it) * 1983-02-16 1986-03-27 Sigma Tau Ind Farmaceuti Composizione farmaceutica ad azione metabolica ed energetica utilizzabile in terapia cardiaca e vascolare.
CH670763A5 (https=) * 1985-08-02 1989-07-14 Seuref Ag

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
NICHTS ERMITTELT *

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996018403A1 (en) * 1994-12-16 1996-06-20 Ks Biomedix Ltd. Combined use of diclofenac and tribenoside to treat osteoarthritis
US6034122A (en) * 1994-12-16 2000-03-07 Ks Biomedix Ltd. Combined use of diclofenac and tribenoside to treat osteoarthritis
US6369107B1 (en) 1994-12-16 2002-04-09 Ks Biomedix Ltd. Combined use of diclofenac and tribenoside to treat osteoarthritis

Also Published As

Publication number Publication date
GB2174904A (en) 1986-11-19
CH662505A5 (it) 1987-10-15
GB8610147D0 (en) 1986-05-29
BE904696A (nl) 1986-08-18
NL8601105A (nl) 1986-11-17
JPS61280424A (ja) 1986-12-11
KR860007927A (ko) 1986-11-10
FR2587212A1 (fr) 1987-03-20
AT393793B (de) 1991-12-10
ATA115186A (de) 1991-06-15
JPH0344048B2 (https=) 1991-07-04
GB8610588D0 (en) 1986-06-04
GB2174904B (en) 1989-07-05
FR2587212B1 (fr) 1992-05-29
US4707360A (en) 1987-11-17

Similar Documents

Publication Publication Date Title
AT393793B (de) Verfahren zur herstellung eines pharmazeutischen praeparates mit gefaesschuetzender wirkung
DE3856442T2 (de) Verwendung von sulfatierten Zuckern gegen Entzundung
EP2214658B2 (de) Osmolythaltige zubereitung zur anwendung bei trockenen schleimhäuten
DE60118019T2 (de) Zusammensetzung enthaltend hydroxyzitronensäure und garcinol zur gewichtsreduzierung
DE69127658T2 (de) Haarregenerierendes Mittel
DE69025603T2 (de) Kosmetische zubereitung
DE60004797T2 (de) Arzneimittel mit verzögerter wirkstoffabgabe enthaltend isoquercetin und ascorbinsäure
DE60012230T2 (de) Verwendung einer oligosaccharide enthaltenden dermatologischen zubereitung zur behandlung von hauterkrankungen
DE69825279T2 (de) Verwendung von glukosamin und glukosaminderivaten zur schnellen linderung von juckreiz oder lokalisiertem schmerz
DE69524662T2 (de) Topisches Arzneimittel mit vernarbungsfördernder Wirkung
DE602004006271T2 (de) Kombination vasoaktiver agentien und deren verwendung zur behanldung sexueller störungen
DE102008036725B4 (de) Pharmazeutische Zusammensetzung für die nasale Applikation
DE2164052A1 (de) Kosmetische mittel mit nucleosidderivaten
DE69634472T2 (de) Adrenal-Cortikosteroide enthaltende therapeutische Zusammensetzung zur äusserlichen Anwendung für Dermatitis-Behandlung
DE102010007736A1 (de) Zubereitungen zur Stabilisierung/Aufbau (Forming) der Textur lebender Gewebe wie Haut incl. Anhangsgebilde und deren Anwendungen
DD272034A5 (de) Verfahren zur herstellung einer praeparation zur regulierung des gewebewachstums
DE3432661A1 (de) Carcinom-therapeutikum
DE60311595T2 (de) Zusammensetzung zur behandlung von gastrointestinalen beschwerden
DE69120933T2 (de) Topische Anwendung von Glycosaminoglykane zur Prävention und Behandlung der Zervikal- oder Vaginalerkrankungen
CH662510A5 (de) Glycyrrhizin und einen wirkstoff enthaltendes arzneimittel.
DE69424679T2 (de) Zusammensetzung zur behandlung oder vorbeugung von herpes
DE2619100A1 (de) Verwendung von glucuronsaeure oder glucuronsaeure-gamma-lacton als hemmstoff fuer beta-glucuronidase
WO2001034169A1 (de) Verwendung eines extraktes aus plantago lanceolata
AT403434B (de) Topische zusammensetzung zur beschleunigung der wundheilung
DE68905076T2 (de) Pharmazeutische Zusammensetzung für die Behandlung von Hautwunden.

Legal Events

Date Code Title Description
8110 Request for examination paragraph 44
8125 Change of the main classification

Ipc: A61K 31/35

D2 Grant after examination
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE S.P.A.,

8328 Change in the person/name/address of the agent

Free format text: DERZEIT KEIN VERTRETER BESTELLT

8328 Change in the person/name/address of the agent

Free format text: HOFFMANN * EITLE, 81925 MUENCHEN

8339 Ceased/non-payment of the annual fee